Advertisement

Severe Legionellosis

  • María Bodí
  • José Antonio Porras
Chapter

Abstract

Legionnaires’ disease is a form of pneumonia, caused by bacteria of the genus Legionella. In contrast, Pontiac fever is a self-limited influenza-like illness, without pneumonia, that is associated with Legionella spp too. The name of this infection is in reference to an outbreak of pneumonia that affected 221 people and caused 34 deaths during the 58th American Legion Convention celebrated in Philadelphia during the summer of 1976 [1]. Epidemiologically, the Philadelphia outbreak was similar in many aspects to two large outbreaks of febrile disease, one in 1965 (District of Columbia) and the other in 1968 (Pontiac, Michigan). The Columbia outbreak involved patients in a large psychiatric hospital in which there were 81 cases and 12 deaths [2]. The Pontiac outbreak was very different, of the 144 documented cases neither death nor pneumonia were demonstrated.

Keywords

Urinary Antigen Severe Community Pontiac Fever Semin Respir Infect Nosocomial Legionellosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fraser DW, Tsai T, Orenstein W, et al. Legionnaires’ disease: description of an epidemic of pneumonia. N Engl J Med 297:1189, 1977.PubMedCrossRefGoogle Scholar
  2. 2.
    Thacker SB, Bennet JV, Tsai T, et al. An outbreak in 1965 of severe respiratory illness caused by legionnaires’ disease bacterium. J Infect Dis 238:512, 1978.CrossRefGoogle Scholar
  3. 3.
    Kaufmann AF, McDade JE, Patton CM, et al. Pontiac fever: isolation of the etiologic agent (Legionella pneumophila) and demonstration of its mode of transmission. Am J Epidemiol 114: 337, 1981.PubMedGoogle Scholar
  4. 4.
    McDade JE, Brenner DJ, Bozeman M. Legionnaires’ disease bacterium isolated in 1947. Ann Intern Med 90:659, 1979.PubMedCrossRefGoogle Scholar
  5. 5.
    Muder RR, Yu VL, Fang GD. Community-acquired Legionnaires’ disease. Semin Respir Infect 3:32, 1989.Google Scholar
  6. 6.
    Woodhead MA, Macfarlane JT, Rodgers FG, Laverick A, Pilkintong R, Macrae AD. Aetiology and outcome of severe community-acquired pneumonia. J Infect 10:204, 1985.PubMedCrossRefGoogle Scholar
  7. 7.
    Sorensen J, Cederholm I, Carlsson C. Pneumonia: a deadly disease a despite intensive care treatment. Scand J Infect Dis 18:329, 1986.PubMedCrossRefGoogle Scholar
  8. 8.
    Pachón J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A. Severe community-adquired pneumonia: etiology prognosis and treatment. Am Rev Respir Dis 142:369, 1990.PubMedCrossRefGoogle Scholar
  9. 9.
    Torres A, Serra-Batlles J, Ferrer A, Jimenez P, Celis R, Cobo E, et al. Severe community-adquired pneumonia: epidemiology and prognostic factors. Am Rev Respir Dis 144:312, 1991.PubMedCrossRefGoogle Scholar
  10. 10.
    Rello J, Quintana E, Ausina V, Net A, Prats G. A three-year study of severe community-acquired pneumonia with emphasis on outcome. Chest 103:232, 1993.PubMedCrossRefGoogle Scholar
  11. 11.
    Moine P, Vercken JB, Chevret S, Chastang C, Gajdos P, ICU French Study Group for SCAP Severe community-acquired pneumonia. Etiology, epidemiology and prognosis factors. Chest 105:1487, 1994.PubMedCrossRefGoogle Scholar
  12. 12.
    Leroy O, Santré C, Beuscart C, Georges H, Guery B, Jacquier JM, Beucaire G. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 21:24, 1995.PubMedCrossRefGoogle Scholar
  13. 13.
    Rello J, Rodriguez R, Jubert P, Álvarez B Study Group for Severe community-acquired pneumonia. Severe community-acquired pneumonia in the elderly. Epidemiology and prognosis. Clin Infect Dis 23:723, 1996.PubMedCrossRefGoogle Scholar
  14. 14.
    Hirani NA, Macfarlane JT. Impact of management guidelines on the outcome of severe community acquired pneumonia. Thorax 52:17, 1997.PubMedCrossRefGoogle Scholar
  15. 15.
    Redón J, Borrás R, Vila B, Garcia de Lomas J, Pascual JM, Prat J, Uriel B, Perez M. A prospective study of nosocomial pneumonia by Legionella pneumophila. Med Clin (Bare) 87:363, 1986.Google Scholar
  16. 16.
    Kirby BA, Snyder KM, Meyer RD, Finegold SM. Legionnaires’ disease: report of sixty-five nosocomially acquired cases and review of the lierature. Medicine 59:188, 1980.PubMedCrossRefGoogle Scholar
  17. 17.
    Redón J, Pascual JM, Vila B, et al. A comparative adquired Legionella pneumophila pneumonia and pneumonia by other microorganisms. Med Clin (Bare) 88:349, 1987.Google Scholar
  18. 18.
    Woodhead MA, Macfarlane JT. Legionnaires’ disease: a review of 79 community-acquired cases in Nottingham. Thorax 41:635, 1986.PubMedCrossRefGoogle Scholar
  19. 19.
    Heath CH, Grove DI, Looke DFM. Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. Eur J Clin Microbiol Infect Dis 15:286, 1996.PubMedCrossRefGoogle Scholar
  20. 20.
    McDade JE, Shepard CC, Fraser DW, et al. Legionnaires’ disease: isolation of a bacterium. N Engl J Med 297:1197, 1977.PubMedCrossRefGoogle Scholar
  21. 21.
    Thacker WL, Dyke JW, Benson RF, et al. Legionella lansingensis sp. isolated from a patient with a pneumonia and underlying chronic lymphocytic leukemia. J Clin Microbiol 30:2389, 1992.Google Scholar
  22. 22.
    Roig J, Domingo C, Morera J. Legionnaires’ disease. Chest 105:1817, 1994.PubMedCrossRefGoogle Scholar
  23. 23.
    Fang GD, Yu VL, Vickers RM. Disease due to the Legionellaceae (other than Legionella pneumophila). Historical, microbiological, clinical, and epidemiolgical review. Medicine 68:116, 1989.PubMedCrossRefGoogle Scholar
  24. 24.
    Joseph CA, Watson JM, Harrison TG, Barlett CLR. Nosocomial Legionnaires’ disease in England and Wales, 1980–92. Epidemiol Infect 112:329, 1994.PubMedCrossRefGoogle Scholar
  25. 25.
    Leverstein-van Hall M, Verbon A, Huisman MV, Kuijper EJ, Dankert J. Reinfection with Legionella pneumophila documented by pulsed-field gel electrophoresis. Clin Infect Dis 19: 1147, 1994.PubMedCrossRefGoogle Scholar
  26. 26.
    Stout JE, Yu VL, Muraca P, Joly J, Troup N, Tompkins LS. Potable water as a cause of sporadic cases of community-acquired legionnaires’ disease. N Engl J Med 326:151, 1992.PubMedCrossRefGoogle Scholar
  27. 27.
    Muder RR, Yu VL, Woo AH. Mode of transmission of Legionella pneumophila: a critical review. Arch Intern Med 146:1607, 1986.PubMedCrossRefGoogle Scholar
  28. 28.
    Addiss DG, Davis JP, La Ventura M, Wand PJ, Hutchinson MA, Mckinney RM. Community-acquired Legionnaires’ disease associated with cooling tower: evidence for longer-distance transport of Legionella pneumophila. Am J Epidemiol 130:557, 1989.PubMedGoogle Scholar
  29. 29.
    Keller DW, Hajjch R, DcMaria A, et al. Community outbreak of Legionnaires’ disease: an investigation confirming the potential for cooling towers to transmit Legionella species. Clin Infect Dis 22:257, 1996.PubMedCrossRefGoogle Scholar
  30. 30.
    Stout JE, Yu VL, Yee YC, Vaccarello S, Diven W, Lee TC. Legionella pneumophila in residential water supplies: environmental surveillance with clinical assessment for Legionnaires’ disease. Epidemiol Infect 109:49, 1992.PubMedGoogle Scholar
  31. 31.
    Straus WL, Plouffe JF, File TM Jr, et al. Risk factors for domestic acquisition of legionnaires disease. Ohio legionnaires Disease Group. Arch Intern Med 156:1685, 1996.PubMedCrossRefGoogle Scholar
  32. 32.
    Garbe PL, Davis BJ, Weisfeld JS. Nosocomial legionnaires’ disease: epidemiological demonstration of cooling towers as a source. JAMA 254:521, 1985.PubMedCrossRefGoogle Scholar
  33. 33.
    Dondero TJ, Rentdorff RC, Mallison GF. An outbreak of legionnaires’ disease associated with a contaminated air-conditioning cooling tower. N Engl J Med 302:365, 1980.PubMedCrossRefGoogle Scholar
  34. 34.
    Breiman RF, Cozen W, Fields BS. Role of air-sampling in an investigation of an outbreak of legionnaires’ disease associated with exposure to aerosols from an evaporative condenser. J Infect Dis 161:1257, 1990.PubMedCrossRefGoogle Scholar
  35. 35.
    Breiman RF, Fields BS, Sanden GN, Volmer M, Meier A, Spika JS. An outbreak of legionnaires’ disease associated with shower use: possible role of amoebae. JAMA 263:2924, 1990.PubMedCrossRefGoogle Scholar
  36. 36.
    Jernigan DB, Hofmann J, Cetron MS, et al. Outbreak of Legionnaires’ disease among cruise ship passengers exposed to a contaminated whirlpool spa. Lancet 347:494, 1996.PubMedCrossRefGoogle Scholar
  37. 37.
    Den Boer JW, Yzerman E, Van Belkum A, Vlaspolder F, Van Breukelen FJM. Legionnaire’s disease and saunas. Lancet 351:114, 1998.CrossRefGoogle Scholar
  38. 38.
    Woo AH, Goetz A, Yu VL. Transmission of Legionella by respiratory equipment and aerosol generating devices. Chest 102:1586, 1992.PubMedCrossRefGoogle Scholar
  39. 39.
    Mastro TD, Fields BS, Breiman RF, Campbell J, Plikaytis BD, Spika JS. Nosocomial Legionnaires’ disease and use of medication nebulizers. JID 163:667, 1991.PubMedCrossRefGoogle Scholar
  40. 40.
    Blatt SP, Parkinson MD, Pace E. Nosocomial Legionnaires’ disease: aspiration as a primary mode of disease acquisition. Am J Med 95:16, 1993.PubMedCrossRefGoogle Scholar
  41. 41.
    Venezia RA, Agresta MD, Hanley EM, Urquhart K, Schoonmaker D. Nosocomial legionellosis associated with aspiration of nasogastric feedings diluted in tap water. Infect Control Hosp Epidemiol 15:529, 1994.PubMedCrossRefGoogle Scholar
  42. 42.
    Johnson JT, Yu VL, Best MG. Nosocomial legionellosis in patients with head-and-neck cancer: implications for epidemiological reservoir and mode of transmission. Lancet 2:298, 1985.PubMedCrossRefGoogle Scholar
  43. 43.
    Lowry PW, Blankenship RJ, Gridley W, Troup NJ, Tompkins LS. A cluster of Legionella sternal-wound infections due to postoperative topical exposure to contaminated tap water. N Engl J Med 324:109, 1991.PubMedCrossRefGoogle Scholar
  44. 44.
    Yu VL, Zuravleff JJ, Gavlik L, Magnussen MH. Lack of evidence for person-to-person transmission of Legionnaires’ disease. J Infect Dis 147: 362, 1983.PubMedCrossRefGoogle Scholar
  45. 45.
    Barker J, Brown MR, Collier PF, Farrell I, Gilbert P. Relationship between Legionella pneumophila and Acanthamoeba polyphaga: physiological status and susceptibility to chemical inactivation. Appl Environ Microbiol 58:2420, 1992.PubMedGoogle Scholar
  46. 46.
    Vogel JP, Andrews HL, Wong SK, Isberg RR. Conjugative transfer by the virulence system of Legionella pneumophila. Science 279:873, 1998.PubMedCrossRefGoogle Scholar
  47. 47.
    Miyamoto H, Maruta K, Ogawa M, Beckers MC, Gros P, Yoshida S. Spectrum of Legionella species whose intracellular multiplication in murine macrophages is genetically controlled by Lgnl. Infect Immun 64:1842, 1996.PubMedGoogle Scholar
  48. 48.
    Andrews HL, Vogel JP, Isberg RR. Identification of linked Legionella pneumophila genes essential for intracellular growth and evasion of the endocytic pathway. Infect Immun 66:950, 1998.PubMedGoogle Scholar
  49. 49.
    Pruckler J, Benson R, Martin W, Fields B. Association of flagella and intracellular growth of L. pneumophila. In: Abstracts of the 95th General Meeting of the American Society for Microbiology, Washington, D.C., May 21–25, 7:7, 1995.Google Scholar
  50. 50.
    American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 148:1418, 1993.CrossRefGoogle Scholar
  51. 51.
    Barlett JG, Dowell SF, Mandell LA, File TM. Musher DM, Fine MS. Community-acquired pneumonia in adults. Practice guidelines for the management of CID 31:347, 2000.Google Scholar
  52. 52.
    American Thoracic Society. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement. Am J Respir Crit Care Med 153: 1711, 1995.Google Scholar
  53. 53.
    Roig J, Aguilar X, Ruiz J, et al. Comparative study of Legionella pneumophila and other nosocomial-aquired pneumonias. Chest 99:344, 1991.PubMedCrossRefGoogle Scholar
  54. 54.
    Carratala J, Gudiol F, Pallares R, et al. Risk factors for nosocomial Legionella pneumophila pneumonia. Am J Respir Crit Care Med 149:625, 1994.PubMedCrossRefGoogle Scholar
  55. 55.
    Blatt SP, Dolan MJ, Hendrix CW, Melcher GP. Legionnaires’ disease in human immunodeficiency virus-infected patients: eight cases and review. Clin Infect Dis 18:227, 1994.PubMedCrossRefGoogle Scholar
  56. 56.
    Korvick JA, Yu VL. Legionnaires’ disease: an emerging surgical problem. An Thorac Surg 43:341, 1987.CrossRefGoogle Scholar
  57. 57.
    Chow JW, Yu VL. Legionella: a major opportunistic pathogen in transplant recipients. Semin Respir Infect 13:132, 1998.PubMedGoogle Scholar
  58. 58.
    Spieker S, Petersen D, Rolfs A, et al. Acute disseminated encephalomyelitis following Pontiac fever. Eur Neurol 40:169, 1998.PubMedCrossRefGoogle Scholar
  59. 59.
    Stout JE, Yu VL. Legionellosis. New Engl J Med 337:682, 1997.PubMedCrossRefGoogle Scholar
  60. 60.
    Edelstein PH. Legionnaires’ disease. CID 16: 741, 1993.CrossRefGoogle Scholar
  61. 61.
    Hoge CW, Breiman RF. Advances in the Epidemiology and control of Legionella infections. Epid Rev 13:329, 1991.Google Scholar
  62. 62.
    Pedro-Botet ML, Sabria-Leal M, Haro M, et al. Nosocomial and community-acquired Legionella pneumonia: clinical comparative analysis. Eur Respir J 8:1929, 1995.PubMedCrossRefGoogle Scholar
  63. 63.
    Yu, VL, Kroboth FJ, Shonnard J, Brown A, McDearman S, Magnussen M. Legionnaires’ disease: new clinical perspective from a prospective pneumonia study. Am J Med 73:357, 1982.PubMedCrossRefGoogle Scholar
  64. 64.
    Falco V, Fernández de Sevilla T, Alegre J, Ferrer A, Martínez Vázquez JM. Legionella pneumophila: a cause of severe community-acquired pneumonia. Chest 100:1007, 1991.PubMedCrossRefGoogle Scholar
  65. 65.
    Sopena N, Sabrià-Lal M, Pedro-Botet ML, et al. Comparative study of the clinical presentation of Legionella pneumona and other community-acquired pneumonias. Chest 113:1195, 1998.PubMedCrossRefGoogle Scholar
  66. 66.
    Johnson JD, Raff M, VanArsdall J. Neurologic manifestations of legionnaires’ disease. Medicine 63:303, 1984.PubMedCrossRefGoogle Scholar
  67. 67.
    Kirby BD, Peck H, Meyer RD. Radiographic features or legionnaires’ disease. Chest 76:562, 1979.PubMedCrossRefGoogle Scholar
  68. 68.
    Roig J, Martinez-Benitez J, Salvador J. Radiologic features of legionellosis. Curr Top Radiol 1:101, 1998.Google Scholar
  69. 69.
    Coletta FS, Fein AM. Radiological manifestations of Legionella/Legionella-like organisms. Semin Respir Infect 13:109, 1998.PubMedGoogle Scholar
  70. 70.
    Domingo C, Roig J, Planas F, Bechini J, Tenesa M, Morera J. Radiographic appearance of nosocomial legionnaires’ disease after erythromycin treatment. Thorax 46:663, 1991.PubMedCrossRefGoogle Scholar
  71. 71.
    El-Ebiary M, Sarmiento X, Torres A, et al. Prognosis factors of severe Legionella pneumonia requiring admission to ICU. Am J Respir Crit Care Med 156:1467, 1997.PubMedCrossRefGoogle Scholar
  72. 72.
    Pedro-Botet ML, Sabria-Leal M, Sopena N, et al. Role of immunosppression in the evolution of Legionnaires’ disease. CID 26:14, 1998.CrossRefGoogle Scholar
  73. 73.
    Nelson D, Rensimer E, Raffin T. Legionella pneumophila pericarditis without pneumonia. Arch Intern Med 145:926, 1985.PubMedCrossRefGoogle Scholar
  74. 74.
    White HJ, Felton WW, Sun CN. Etrapul-monary histopathologic manifestations of Legionnaires’ disease. Arch Pathol Lab Med 104:287, 1980.PubMedGoogle Scholar
  75. 75.
    Tompkins LS, Roessler BJ, Redd SC, Markowitz LE, Cohen ML. Legionella prosthetic-valve endocarditis. N Engl J Med 318:530, 1988.PubMedCrossRefGoogle Scholar
  76. 76.
    Brabender W, Hinthorn DR, Asher M, et al. Legionella pneumophila wound infection. JAMA 250:3091, 1983.PubMedCrossRefGoogle Scholar
  77. 77.
    Andersen BB, Sogaard I. Legionnaires’ disease and train abscess. Neurology 37:333, 1987.PubMedCrossRefGoogle Scholar
  78. 78.
    Arnow PM, Boyko EJ, Friedman EL. Perirectal abscess caused by Legionella pneumophila and mixed anaerobic bacteria. Ann Intern Med 98: 184, 1983.PubMedCrossRefGoogle Scholar
  79. 79.
    Dournon E, Bure A, Kemeny JL, et al. Legionella pneumophila peritonintis (Letter). Lancet 1: 1363, 1982.PubMedCrossRefGoogle Scholar
  80. 80.
    Westblom TU, Hamory BH. Acute pancreatitis caused by Legionella pneumophila. South Med J 81:1200, 1988.PubMedCrossRefGoogle Scholar
  81. 81.
    Parenti DM, Steinberg W, Kang P. Infectious causes of acute pancreatitis. Pancreas 13:356, 1996.PubMedCrossRefGoogle Scholar
  82. 82.
    Byrd RP, Fields CL, Roy TM. Prognostic factors in Legionella pneumonia. Am J Respir Crit Care Med 159:342, 1999.PubMedCrossRefGoogle Scholar
  83. 83.
    Dorman SA, Hardin NJ, Winn WC. Pyelonephritis associated with Legionella pneumophila, serogroup 4. Ann Intern Med 93:835, 1980.PubMedCrossRefGoogle Scholar
  84. 84.
    Schlanger G, Lutwick LI, Kurzman M, et al. Sinusitis caused by Legionella pneumophila in a patient with the acquired immune deficiency syndrome. Am J Med 77:957, 1984.PubMedCrossRefGoogle Scholar
  85. 85.
    Kalweit WC, Winn WC Jr, Rocco TA Jr, et al. Hemodialysis fistula infections caused by Legionella pneumophila. Ann Intern Med 96: 173, 1982.PubMedCrossRefGoogle Scholar
  86. 86.
    Waldor MK, Wilson B, Swartz M. Cellulitis caused by Legionella pneumophila. Clin Infect Dis 16:51, 1993.PubMedCrossRefGoogle Scholar
  87. 87.
    Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine 69:307, 1990.PubMedCrossRefGoogle Scholar
  88. 88.
    Chandler FW, Hicklin MD, Blackmon JA. Demostration of the agent of Legionnaires’ disease in tissue. N Engl J Med 297:1218, 1977.PubMedCrossRefGoogle Scholar
  89. 89.
    Edelstein PH, Meyer RD, Finegold SM. Laboratory diagnosis of Legionnaires disease. Am Rev Respir Dis 121:317, 1980.PubMedGoogle Scholar
  90. 90.
    Ruf B, Schürman D, Horback I, Fehrenbach FJ, Pohle HD. Prevalence and diagnosis of Legionella pneumonia: a 3-year prospective study with emphasis on application of urinary antigen detection. J Infect Dis 162:1341, 1990.PubMedCrossRefGoogle Scholar
  91. 91.
    Ingram JG, Plouffe JF. Danger of sputum purulence screens in culture of Legionella species. J Clin Microbiol 32:209, 1994.PubMedGoogle Scholar
  92. 92.
    Edelstein PH. Laboratory diagnosis of infections caused by Legionellae. Eur J Clin Microbiol 6:216, 1987.PubMedCrossRefGoogle Scholar
  93. 93.
    Kohorst WR, Schonfeld SA, Macklin JE, Whitcomb ME. Rapid diagnosis of legionnaires’ disease by bronchoalveolar lavage. Chest 84: 186, 1983.PubMedCrossRefGoogle Scholar
  94. 94.
    Monforte R, Estruch R, Vidal J, Cervera R, Urbano-Márquez A. Delayed seroconversion, Legionnaires’ disease, and age. Lancet 2:1190, 1988.CrossRefGoogle Scholar
  95. 95.
    Wilkinson HW, Reingold AL, Brake BJ, McGiboney DL, Gorman GW, Broome CV. Reactivity of serum from patients with suspected legionellosis against 29 antigens of legionellaceae and Legionella-like organisms by indirect immunofluorecent assay. J Infect Dis 147:23, 1983.PubMedCrossRefGoogle Scholar
  96. 96.
    Plouffe JF, File TM Jr, Breiman RF, et al. Reevaluation of the definition of Legionnaires’ disease: use of the urinary antigen assay. Clin Infect Dis 20:1286, 1995.PubMedCrossRefGoogle Scholar
  97. 97.
    Dominguez JA, Manterola JM, Blavia R, et al. Detection of Legionella pneumophila serogroup 1 antigen in nonconcentrated urine and urine concentrated by selective ultrafiltration. J Clin Microbiol 34:2334, 1996.PubMedGoogle Scholar
  98. 98.
    Dominguez JA, Gali N, Pedroso P, et al. Comparison of the Binax Legionella urinary antigen enzyme immumoassay (EIA) with the Biotest Legionella urin antigen EIA for detection of Legionella antigen in both concentrated and nonconcentrated urine samples. J Clin Microbiol 36:2718, 1998.PubMedGoogle Scholar
  99. 99.
    Kazandjian D, Chiew R, Gilbert GL. Rapid diagnosis of Legionella pneumophila serogroup 1 infection with the Binax enzyme immunoassay urinary antigen test. J Clin Microbiol 35: 954, 1997.PubMedGoogle Scholar
  100. 100.
    Wever PC, Kuijper EJ, Yzerman EPF, Speel-man P, Dankert J, Van Ketel RJ. Significance of the Legionella urinary antigen test during an outbreak. Abstracts of the 39th Interscience Conference on Antimicrobial and Chemotherapy, September 1999; Abstract 226:195, 1999.Google Scholar
  101. 101.
    Dominguez J A, Matas L, Manterola JM, et al. Comparison of radiommunoassay and enzyme immunoassay kits for detection of Legionella pneumophila serogroup 1 antigen in both concentrated and nonconcentrated urine samples. J Clin Microbiol 35:1627, 1997.PubMedGoogle Scholar
  102. 102.
    Kohler RB, Winn WC Jr, Wheat LJ. Onset and durating of urinary antigen excretion in Legionnaires disease. J Clin Microbiol 20:605, 1984.PubMedGoogle Scholar
  103. 103.
    Pasculle AW, Veto GE, Kristofiak S, McKelvey K, Vrsalovic K. Laboratory and clinical evaluation of a commercial DNA probe for the detection of Legionella spp. J Clin Microbiol 27:2350, 1989.PubMedGoogle Scholar
  104. 104.
    Pelloux I, Croize J, Hirtz P, Comet M, Le Noc P. Evaluation d’une tecnique de détection de Legionella spp par sonde nucléique. Pathol Biol 39:150, 1991.PubMedGoogle Scholar
  105. 105.
    Jaulhac B, Nowicki M, Bornstein N, et al. Detection of Legionella spp in bronchoalveolar lavage fluids by DNA amplification. J Clin Microbiol 30:920, 1992.PubMedGoogle Scholar
  106. 106.
    Kessler HH, Reinthaler FF, Pschaid A, et al. Rapid detection of Legionella species in bronchoalveolar lavage fluids with the EnviroAmp Legionella PCR amplification and detection kit. J Clin Microbiol 31:3325, 1993.PubMedGoogle Scholar
  107. 107.
    Matsiota-Bernard P, Pitsouni E, Legakis N, Nauciel C. Evaluation of commercial amplification kit for detection of Legionella pneumophila in clinical specimen. J Clin Microbiol 32:1503, 1994.PubMedGoogle Scholar
  108. 108.
    Weir SC, Fischer SH, Stock F, Gill VJ. Detection of Legionella by PCR in respiratory specimens using a commercially available kit. Am J Clin Pathol 110:295, 1998.PubMedGoogle Scholar
  109. 109.
    Koide M, Saito A. Diagnosis of Legionella pheneumophila infection by polymerase chain reaction. Clin Infect Dis 21:199, 1995.PubMedCrossRefGoogle Scholar
  110. 110.
    Maiwald M, Schill M, Stockinger C, et al. Detection of Legionella DNA in human and guinea pig urine samples by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis 14:25, 1995.PubMedCrossRefGoogle Scholar
  111. 111.
    Murdock DR, Walford EJ, Jenneings LC, et al. Use of the polymerase chain reaction to detect Legionella DNA in urine and serum samples from patients with pneumonia. Clin Infect Dis 23:475, 1996.CrossRefGoogle Scholar
  112. 112.
    Ramirez J A, Ahkee S, Tolentino A, Miller RD, Summergill JT. Diagnosis of Legionella pheumophila, Mycoplasma pneumoniae, or Chamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen. Diagn Microbiol Infect Dis 24:7, 1996.PubMedCrossRefGoogle Scholar
  113. 113.
    Lindsay DS, Abraham WH, Fallon RJ. Detection of mip gene by PCR for diagnosis of Legionnaires’ disease. J Clin Microbiol 32: 3068, 1994.PubMedGoogle Scholar
  114. 114.
    Akane A, Matsurbara K, Nakamura H, et al. Identification of the heme compound copurified with deoxyribonucleic acid (DNA) from bloodstains: a major inhibitor of polymerase chain reaction (PCR) amplification. J Forensic Sci 39:362, 1994.PubMedGoogle Scholar
  115. 115.
    Edelstein PH, Calarco K, Yasui VK. Antimicrobial therapy of experimentally induced Legionnaires’ disease in guinea pigs. Am Rev Respir Dis 130:849, 1984.PubMedGoogle Scholar
  116. 116.
    Ewing S, Torres A. Severe community-acquired pneumonia. Clin Chest Med 20:575, 1999.CrossRefGoogle Scholar
  117. 117.
    Roig J, Carreres A, Domingo C. Treatment of Legionnaires’ disease. Drugs 46:63, 1993.PubMedCrossRefGoogle Scholar
  118. 118.
    Edelstein PH. Antimicrobial chemotherapy for Legionnaires’ disease: a review. CID 21(Suppl 3):S265, 1995.CrossRefGoogle Scholar
  119. 119.
    Klein NC, Cunha BA. Treatment of Legionnaires’ disease. Semin Respir Infect 13:140, 1998.PubMedGoogle Scholar
  120. 120.
    O’Doherty B, Muller O. Randomized, multicentre study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of adults with mild to moderate community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 17:823, 1998.Google Scholar
  121. 121.
    Garey KW, Amsden GW. Intravenous azithromycin. Ann Pharmacother 33:218, 1999.PubMedCrossRefGoogle Scholar
  122. 122.
    Edelstein PH. Antimicrobial chemotherapy for Legionnaires’ disease: time for a change. Ann Intern Med 129:328, 1998.PubMedCrossRefGoogle Scholar
  123. 123.
    Reda C, Quaresima T, Pastoris MC. In-vitro activity of six intracellular antibiotics against Legionella pneumophila strains of human and enviromental origin. J Antimicrob Chemother 33:757, 1994.PubMedCrossRefGoogle Scholar
  124. 124.
    Baltch AL, Smith RP, Ritz W. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin and rifampicin used singly and in combination against Legionella pneumophila. Antimicrob Agents Chemother 39: 1661, 1995.PubMedCrossRefGoogle Scholar
  125. 125.
    Martin SJ, Pendland SL, Chen C, Schreckenberg P, Danzinger LH. In vitro sinergy testing of macrolide-quinolone combination against 41 clinical isolates of Legionella. Antimicrob Agents Chemother 40:1419, 1996.PubMedGoogle Scholar
  126. 126.
    Plouffe JF, Para MF, Bollin GE. Sulfamethoxazole-trimethoprim treatment of guinea pigs infected with Legionella pneumophila. J Infect Dis 150:780, 1984.PubMedCrossRefGoogle Scholar
  127. 127.
    Ruiz-Santana S, Aguado-Bourrey JM, Narvaez-Bermejo JM, Gonzalez-Mediero G. Legionella bozemanii pneumonia and tetracycline [letter]. Ann Intern Med 105:969, 1986.PubMedCrossRefGoogle Scholar
  128. 128.
    Morely JN, Smith LC, Baltch AL, Smith RP. Recurrent infection due to Legionella pneumophila in a patient with AIDS. Clin Infect Dis 19:1130, 1994.CrossRefGoogle Scholar
  129. 129.
    Rello J, Valles J. Hospital-acquired pneumonia in the ICU patient. Semin Respir Crit Care Med 18:133, 1997.CrossRefGoogle Scholar
  130. 130.
    Byrd RP, Roy TM. Rhabdomyolisis and bacterial pneumonia. Respir Med 92:358, 1998.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • María Bodí
  • José Antonio Porras

There are no affiliations available

Personalised recommendations